Abivax SA (2X1)
Market Closed
10 Aug, 20:00
€
112. 50
+2.1
+1.9022%
€
8.25B Market Cap
- P/E Ratio
- Div Yield
30 Volume
0 Eps
€ 110.4
Previous Close Want to track 2X1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abivax SA (2X1) Statistics
Valuation metrics
Market Cap 8.25B
Enterprise value 7.82B
Trailing P/E (ttm) -21.53
Forward P/E -
PEG ratio -0.13
Price/Sales (ttm) 1,821.79
Price/Book (mrq) 18.12
Enterprise Value/Revenue 1,710.32
Enterprise Value/EBITDA -31.91
Overview
Shares outstanding 78.54M
Float 64.14M
Shares short -
% Held by insiders 0.01%
% Held by institutions 0.51%
Average volume (10 days) 118
Average volume (90 days) 103
Price summary
52-Week low 58.7
52-Week high 133.1
Beta -0.19
50-Day moving average 99.47
200-Day moving average 91.8
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -37.43%
Operational effectiveness
Return on assets -0.39%
Return on equity -1.36%
Income Statement
Revenue (ttm) 4.57M
Revenue per share (ttm) 0.07
Quarterly revenue growth (yoy) -0.55%
Gross profit (ttm) 4.57M
EBITDA -244.98M
Net income to common (ttm) -336.1M
Diluted EPS (ttm) -4.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 530.38M
Total cash per share (mrq) 6.7
Total debt (mrq) 32.09M
Total Debt/Equity (mrq) 7.05
Current ratio (mrq) 8.75%
Book value per share (mrq) 5.8
Cash Flow
Cash flow statement -161.13M
Levered free cash flow (LFCF) -118.32M
